Image pharmaphorum Editor Views & Analysis Cost concerns with the new NHS pricing scheme A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly. Events Partner Content 10th Annual RNA Therapeutics Conference 10th Annual RNA Therapeutics Conference Events Partner Content WIRED Health 2019 Inspirational conference mapping the future of health Views & Analysis Rethinking adherence programmes How digital technologies and behavioural science create adherence programmes that work at scale. Load more results
Views & Analysis Cost concerns with the new NHS pricing scheme A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly.
Events Partner Content 10th Annual RNA Therapeutics Conference 10th Annual RNA Therapeutics Conference
Views & Analysis Rethinking adherence programmes How digital technologies and behavioural science create adherence programmes that work at scale.
News FDA starts review of Regeneron's drug for rare disease FOP Can Regeneron's drug for ultra-rare bone disease FOP pick up the baton from Ipsen's Sohonos, whose growth has stalled?
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
